Thrombolysis in the air: Air-ambulance paramedics flying to remote communities treat patients before hospitalization

Canadian Family Physician

Volumn 46, Issue JUN., 2000, Pages 1313-1319

  Kapasi, Hassanali ^b   Kelly, Len ^a   Morgan, Jonathon ^b  

^a The Clinic   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; RETEPLASE; STREPTOKINASE;

BLOOD CLOT LYSIS; CANADA; FLIGHT; HEART INFARCTION; HUMAN; PARAMEDICAL PERSONNEL; POLICY; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AIR AMBULANCES; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ONTARIO; PILOT PROJECTS; PROGRAM EVALUATION; RURAL HEALTH SERVICES; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0033917753     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Rawles J. Halving mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1994;23(1):1-5.
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1(8478):397-402.
3. Late Assessment of Thrombolytic Efficacy (LATE) study group. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342(8874):759-66.
4. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343(8893):311-22.
5. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329(22):1615-22.
6. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329(10):673-82.
7. Emergency Cardiac Care Coalition. Recommendations for ensuring early thrombolytic therapy for acute myocardial infarction. Can Med Assoc J 1996;154(4):483-511.
8. Thompson J, Balfour N, Butt P, Dodd G, Krym V, Loreto C, et al. Chest pain guidelines and continuous quality improvement system for Canadian rural emergency health care facilities. Can J Rural Med 1999;4(1):9-19.
9. Castaigne AD, Herve C, Duval-Moulin AM, Gaillard M, Dubois-Rande JL, Lellouche D. Prehospital thrombolysis, is it useful? Eur Heart J 1990;11(Suppl F):43-7.
10. Leizorovicz A, Haugh MC, Mercier C, Boissel JP. Prehospital and hospital time delays in thrombolytic treatment in patients with suspected acute myocardial infarction. Analysis of date from the EMIP study. European Myocardial Infarction Project. Eur Heart J 1997;18(2):248-53.
11. Grijseels EW. Bouten MJ, Lenderink T, Deckers JW, Hoes AW, Hartman JA, et al. Prehospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients. Eur Heart J 1995;16(12):1833-8.
12. Boissel JP. The European Myocardial Infarction Project: an assessment of prehospital thrombolysis. Int J Cardiol 1995;49(Suppl):S29-37.
13. European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329(6):383-9.
14. BEPS Collaborative Group. Prehospital thrombolysis in acute myocardial infarction: the Belgian Eminase Prehospital Study (BEPS). Eur Heart J 1991;12(9):965-7.
15. Rawles JM. Myocardial salvage with early anistreplase treatment. Clin Cardiol 1997;20(11 Suppl 3):III6-10.
16. Brouwer MA, Martin JS, Maynard C, Wirkus M, Litwin PE, Verbeugt FW, et al. Influence of early prehospital thrombolysis on mortality and event-free survival (Myocardial Infarction Triage and Intervention Randomized Trial). MITI Project Investigators. Am J Cardiol 1996;78(5):497-502.
17. Aufderheide TP, Keelan MH, Hendley GE, Robinson NA, Hastings TE, Lewin RF, et al. Milwaukee Prehospital Chest Pain Project. Phase I: feasibility and accuracy of prehospital thrombolytic candidate selection. Am J Cardiol 1992;69(12):991-6.
18. Rawles JM. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GKEAT). J Am Coll Cardiol 1997;30(5):1181-6.
19. Rozenman Y, Gotsman MS, Weiss AT, Lotan C, Mosseri M, Sapoznikov D, et al. Early intravenous thrombolysis in acute myocardial infarction: the Jerusalem experience. Int J Cardiol 1995;49(Suppl):S21-8.
20. Staroverov II, Dundua DP, Plotnikov AN, Pomerantsev EV, Bliumenta'l AA, Puchkov AT, et al. The clinical aspects of using thrombolytic therapy in myocardial infarction at the prehospital stage. Kardiologiia 1993;33(3):28-32.
21. Harris SB, Perkins BA, Whalen-Brough E. Non-insulin-dependent diabetes mellitus among First Nations children. New entity among First Nations people of northwestern Ontario. Can Fam Physician 1996;42:869-76.
22. Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, et al. Coronary heart disease prevalence and its relation to risk factors in American Indians: the Strong Heart study. Am J Epidemiol 1995;142(3):254-68.
23. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987;2(8564):871-4.
24. Bett JH. LATE assessment of thrombolytic efficacy with alteplase (rt-PA) six-24 hours after onset of acute myocardial infarction. Aust N Z J Med 1993;23(6):745-8.
25. Steinberg JS, Hochman JS, Morgan CD, Dorion P, Naylor CD, Theroux P, et al. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy. Circulation 1994;90(2):746-52.
26. Shah PK. The role of thrombolytic therapy in patients with acute myocardial infarction presenting later than six hours after the onset of symptoms. Am J Cardiol 1991;68(12):72C-7.
27. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76(1):142-54.
28. Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation 1987;75(4):817-29.
29. Simes RJ, Topol EJ, Holmes DR Jr, White HD, Rutsch WR, Vahanian A, et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 1995;91(7):1923-8.
30. Third International Study of Infarct Survival Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs alteplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339(8796):753-70.
31. Wilcox RG. Clinical trials in thrombolytic therapy: what do they tell us? INJECT 6-month outcomes data. Am J Cardiol 1996;78(12A):20-3.
32. INJECT trial investigators. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 1995;346:329-36.
33. GUSTO III investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997;337(16):1118-23.